Pharmaceuticals by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceuticals ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 14:43 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- SEK 52.32T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | SEK 49.4B | SEK 140.83 | 0.22% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | SEK 92.5B | SEK 974.00 | 2.18% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | SEK 67.9B | SEK 1,001.13 | 2.29% up | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | SEK 54.6B | SEK 1,294.34 | 1.18% up | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | SEK 41B | SEK 299.45 | 0.31% up | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | SEK 76.6B | SEK 975.17 | 0.90% up | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | SEK 49.8B | SEK 884.38 | 0.06% up | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | SEK 97.3B | SEK 643.76 | 1.03% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | SEK 240.4B | SEK 209.73 | 0.93% up | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | SEK 286.1B | SEK 394.81 | 0.37% up | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | SEK 46.8B | SEK 427.38 | 0.05% up | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | SEK 75.8B | SEK 217.55 | 1.37% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | SEK 403.4B | SEK 701.58 | 0.53% up | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | SEK 508.6B | SEK 435.92 | 0.68% up | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | SEK 325.3B | SEK 527.57 | 0.08% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | SEK 87.1B | SEK 3,114.33 | 0.47% up | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | SEK 79.1B | SEK 470.67 | 1.91% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | SEK 700.9B | SEK 219.38 | 0.25% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | SEK 3.53T | SEK 1,433.39 | 1.63% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | SEK 83B | SEK 1,271.37 | 0.36% up | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | SEK 49.8B | SEK 519.29 | 0.01% up | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | SEK 60B | SEK 2,997.66 | 0.41% up | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | SEK 6.81T | SEK 2,828.12 | 0.18% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | SEK 157.8B | SEK 2,457.75 | 0.48% up | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | SEK 1.02T | SEK 9,819.85 | 0.90% up | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | SEK 12.82T | SEK 14,389.20 | 0.05% up | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | SEK 1.27T | SEK 619.53 | 0.67% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | SEK 65.2B | SEK 1,604.15 | 0.10% up | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | SEK 61.2B | SEK 936.76 | 0.26% up | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | SEK 180B | SEK 2,743.43 | 0.44% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | SEK 1.38T | SEK 5,451.65 | 0.43% up | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | SEK 5.24T | SEK 2,964.08 | 0.39% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | SEK 3.03T | SEK 1,602.77 | 0.90% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | SEK 253B | SEK 5,940.55 | 0.09% up | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | SEK 133.5B | SEK 267.04 | 1.66% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | SEK 152.7B | SEK 783.63 | 0.42% up | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | SEK 473.7B | SEK 4,147.30 | 1.24% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | SEK 1.65T | SEK 289.34 | 0.05% up | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | SEK 81.3B | SEK 1,173.11 | 0.99% down | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | SEK 116.2B | SEK 599.82 | 0.89% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | SEK 62B | SEK 438.71 | 0.43% up | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | SEK 1.01T | SEK 501.76 | 0.31% up | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | SEK 126.6B | SEK 151.91 | 1.01% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | SEK 2.85T | SEK 1,840.10 | 0.62% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | SEK 59.7B | SEK 87.69 | 0.00% | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | SEK 1.16T | SEK 484.18 | 0.25% up | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | SEK 72.6B | SEK 1,380.30 | 0.08% down | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | SEK 77.7B | SEK 710.27 | 0.24% down | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | SEK 1.81T | SEK 409.90 | 0.90% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | SEK 1.86T | SEK 1,072.01 | 0.71% up | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | SEK 51.4B | SEK 615.47 | 0.35% up | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | SEK 73.6B | SEK 528.18 | 0.64% up | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | SEK 50.4B | SEK 289.59 | 2.33% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | SEK 99.2B | SEK 4,268.32 | 0.46% down | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | SEK 74.2B | SEK 847.19 | 1.55% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | SEK 347B | SEK 854.10 | 0.69% up | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | SEK 85.2B | SEK 106.49 | 1.78% down | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | SEK 270.9B | SEK 1,234.69 | 0.29% down | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | SEK 33.4B | SEK 172.44 | 5.34% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | SEK 46.2B | SEK 277.40 | 1.26% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | SEK 212.5B | SEK 1,586.27 | 0.25% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1612 SEK).
Questions and answers
Which pharmaceuticals rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceuticals ranked by one-year price change as of 18 Nov 2026, 14:43 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by one-year price change have a combined market value of SEK 52.32T as of 18 Nov 2026, 14:43 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceuticals by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.